Mavupharma raises $20M series A for STING

Mavupharma Inc. (Kirkland, Wash.) raised $20 million in a series A round led by Frazier Healthcare Partners. Alpine BioVentures also participated.

Mavupharma is developing orally bioavailable, non-nucleotide agonists of

Read the full 289 word article

User Sign In